Loading...

Acquisition Of RED And Growth In Cell Therapy Propel Revenue And Margins In Imaging And Healthcare

Published
17 Dec 24
Updated
22 Nov 25
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
1.9%
7D
2.0%

Author's Valuation

JP¥1.55k16.8% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on 01 May 25

Fair value Decreased 6.95%

Shared on 17 Apr 25

Fair value Decreased 1.27%

Shared on 09 Apr 25

Fair value Decreased 1.26%

Shared on 02 Apr 25

Fair value Increased 2.14%

Shared on 19 Mar 25

Fair value Decreased 1.45%